In Brief: Toxikon
This article was originally published in The Gray Sheet
Executive Summary
Toxikon: FDA tells environmental sciences and toxicology testing firm that its response to an April 10 agency warning letter ("The Gray Sheet" May 1, I&W-11) satisfactorily addresses all issues raised by the agency. In a May 4 letter, FDA says that the information provided by the company in an April 12 correspondence "satisf[ies] our concerns expressed in the warning letter." Toxikon reports that "no corrective actions were required"...